Dixon Jonathan V. 4
4 · Bionano Genomics, Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Bionano Genomics (BNGO) GC Jonathan Dixon Withholds 6 Shares for Taxes
What Happened Jonathan V. Dixon, General Counsel of Bionano Genomics (BNGO), had 6 shares of common stock withheld by the company on Feb 17, 2026 to satisfy tax withholding obligations related to RSUs that vested on Feb 15, 2026. The withholding was reported as a disposal at an effective price of $1.10 per share, totaling about $7. This is a routine tax-withholding transaction (code F), not an open-market sale or purchase.
Key Details
- Transaction date: 2026-02-17; Form 4 filed: 2026-02-18 (Period of Report: 2026-02-17).
- Transaction type/code: F (tax withholding / shares surrendered to satisfy tax liability).
- Shares withheld/disposed: 6 shares at $1.10 each; total value ≈ $7.
- Footnote: Shares were withheld to satisfy tax obligations on RSUs that vested Feb 15, 2026 from an RSU award granted Feb 15, 2023.
- Shares owned after the transaction: not specified in the provided filing.
- Filing timeliness: Filed the day after the transaction (no late-filing flag indicated).
Context Tax withholding via share surrender (a cashless settlement mechanism) is common when RSUs vest and does not necessarily signal any change in the insider’s view of the stock. The amount here is immaterial (~$7) and routine. The F transaction code simply reflects the company withheld shares to cover withholding taxes upon RSU settlement.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-02-17$1.10/sh−6$7→ 263 total
Footnotes (1)
- [F1]The reporting person is reporting the withholding by the Issuer of an aggregate of 6 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.